To access this content, you must purchase a Premium membership, or log in if you are a member.
MilliporeSigma receives $136.7 million federal contract for new Sheboygan production facility
MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, was awarded a $136.7M USD contract award for the construction of a lateral flow membrane production facility over a three-year period at the company’s Sheboygan, Wisconsin site.
MilliporeSigma, the U.S. and Canada life science business of Germany-based Merck, has received a $136.7 million federal contract for a new facility in Sheboygan that will produce a key ingredient used in rapid diagnostic test kits for COVID-19 and other infectious diseases.